Surge Therapeutics
Timothy J Eberlein is Bixby Professor and Chair of the Department of Surgery and The Olin Distinguished Professor of Oncology and Director of The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. He is a past Chair of The Board of The National Comprehensive Cancer Network (NCCN) and a past President of Society of Surgical Oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Surge Therapeutics
SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place and at the right time.